Alfred Chi Yeh Liang

Title: Alfred Chi Yeh Liang: Innovator in Pharmaceutical Compositions

Introduction

Alfred Chi Yeh Liang is a notable inventor based in Rahway, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral compositions for various therapeutic applications. With a total of 2 patents, his work has the potential to impact the treatment of various medical conditions.

Latest Patents

Liang's latest patents include innovative formulations that enhance the delivery of active pharmaceutical ingredients. One of his patents focuses on "Oral pharmaceutical compositions of nicotinamide," which describes compositions for the oral administration of nicotinamide, either alone or in combination with mesalazine. These formulations are designed for delayed-immediate and delayed-extended release, providing therapeutic benefits for patients. Another significant patent is for "Oral pharmaceutical compositions of mesalazine," which outlines similar methodologies for the oral administration of mesalazine, also featuring delayed-release formulations.

Career Highlights

Throughout his career, Alfred Chi Yeh Liang has worked with reputable organizations, including Conaris Research Institute AG and Ferring B.V. His experience in these companies has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Liang has collaborated with various professionals in the field, including his coworker Venkataramana Dingari. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Alfred Chi Yeh Liang's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective drug formulations. His patents reflect a deep understanding of pharmaceutical science and a dedication to enhancing patient outcomes.